18327 Lisette De Pillis/W. Gu/A. Radunskaya: Mixed immunotherapy and chemotherapy
of tumors - modeling, applications and biological interpretations.
J. Theor. Biol. 238 (2006), 841-862.

21167 David Dingli/Jorge Pacheco: Successful cancer treatment - eradication
of cancer stem cells. In M. Hayat (ed.): Methods of cancer diagnosis,
therapy and prognosis. 2nd volume, 179-191. Springer 2008.

1018 Martin Eisen: Mathematical models in cell biology and cancer
chemotherapy. SLN Biomath. 30 (1979).

21471 Jasmine Foo/Franziska Michor: Evolution of resistance to
targeted anti-cancer therapies during continuous and pulsed
administration strategies. PLOS Comp. Biol. 5/11 (2009), 17p.

22299 Jasmine Foo/Franziska Michor: Evolutin of resistance to
anti-cancer therapy during general dosing schedules.
J. Theor. Biol. 263 (2010), 179-188.

26040 Jasmine Foo/Franziska Michor: Evolution of acquired resistance to
anti-cancer therapy. J. Theor. Biol. 355 (2014), 10-20.

20263 Hermann Frieboes/.../Vittorio Cristini: Nanotechnology in cancer
drug therapy - a biocomputational approach.
In A. Lee/L. Lee (ed.): Bio-nanotechnology I. Springer 2006, 435-460.

16072 Yoh Iwasa/Franziska Michor/Martin Nowak: Evolutionary dynamics of
invasion and escape. J. Theor. Biol. 226 (2004), 205-214.

18388 Yoh Iwasa/Martin Nowak/Franziska Michor: Evolution of resistance during
clonal expansion. Genetics 172 (2006), 2557-2566.

18608 Trachette Jackson/Helen Byrne: A mathematical model to study the
effects of drug resistance and vasculature on the response of solid
tumors to chemotherapy. Math. Biosci. 164 (2000), 17-38.

18638 Trachette Jackson/Sharon Lubkin/James Murray: Theoretical analysis
of conjugate localization in two-step cancer chemotherapy.
J. Math. Biol. 39 (1999), 353-376.

18569 Marek Kimmel/Andrzej Swierniak: Using control theory to make cancer
chemotherapy beneficial from phase dependence and resistant to
drug resistance. Internet 2003, 44p.

1017 Helmut Knolle: Cell kinetic modelling and the chemotherapy of cancer.
SLN Biomath. 75 (1988).

18501 Natalia Komarova: Stochastic modeling of drug resistance in cancer.
J. Theor. Biol. 239/3 (2006), 351-366.

18403 Natalia Komarova/Dominik Wodarz: Drug resistance in cancer -
principles of emergence and prevention.
Proc. Nat. Ac. Sci. USA 102 (2005), 9714-9719.

18564 Urszula Ledzewicz/Heinz Schättler: Optimal control for a bilinear
model with recruiting agent in cancer chemotherapy. Internet 2003, 6p.

19378 Ursula Ledzewicz/Heinz Schättler: Analysis of a cell-cycle specific
model for cancer chemotherapy. Internet ca. 2003, 41p.

19379 Ursula Ledzewicz/Heinz Schättler: Drug resistance in cancer
chemotherapy as an optimal control problem. Internet ca. 2004, 22p.

18563 Urszula Ledzewicz/Heinz Schättler: Application of control theory
in modelling cancer chemotherapy. Internet 2004, 6p.

19377 Ursula Ledzewicz/Heinz Schättler: Analysis of models for evolving
drug resistance in cancer chemotherapy. Internet ca. 2005, 14p.

18593 Alexey Matveev/Andrey Savkin: Optimal control applied to drug
administration in cancer chemotherapy - the case of several toxicity
constraints. IMA J. Math. Appl. Med. Biol. 18 (2001), 1-16.

18389 Franziska Michor/Martin Nowak/Yoh Iwasa: Evolution of resistance
to cancer therapy. Curr. Pharm. Design 12 (2006), 261-271.

19392 Gabriela Ochoa/Minaya Villasana/Edmund Burke: An evolutionary approach
to cancer chemotherapy scheduling. Internet 2007, 19p.

18404 John Panetta: A mathematical model of drug resistance -
heterogeneous tumors. Math. Biosci. 147 (1998), 41-61.

20041 Sandeep Sanga/.../Mauro Ferrari/.../Vittorio Cristini: Mathematical
modeling of cancer progression and repsonse to chemotherapy.
Exp. Rev. Anticancer Ther. 6/10 (2006), 1361-1376.

20258 J. Sinek/H. Friboes/X. Zheng/Vittorio Cristini: Two-dimensional
chemotherapy simulations demonstrate fundamental transport and tumor
response limitations involving nanoparticles.
Biomed. Microdevices 6/4 (2004), 297-309.

20265 John Sinek/.../Vittorio Cristini: Mathematical and computational
modeling - towards the development and application of nanodevices for
drug delivery. Internet 2006, 39p.

11995 George Swan: Review of the book "Optimal control of drug
administration in cancer chemotherapy" by Martin/Teo.
Bull. Math. Biol. 57 (1997), 503-504.

26742 George Swan/Thomas Vincent: Optimal control analysis in the chemotherapy
of IgG multiple myeloma. Bull. Math. Biol. 39 (1977), 317-337.

18565 Andrzej Swierniak/Urszula Ledzewicz/Heinz Schättler: Optimal control
for a class of compartmental models in cancer chemotherapy.
J. Appl. Math. Computer Sci. 13/3 (2003), 357-368.
390 T. Wheldon: Mathematical models in cancer research.
Adam Hilger 1988.

19491 Abraham Rami Tzafriri/.../Hanna Parnas: Mathematical modeling and
optimization of drug delivery from intratumorally injected microspheres.
Clin. Cancer Res. 11 (2005), 826-834.

19393 Minaya Villasana/Gabriela Ochoa: Heuristic design of cancer chemotherapies.
IEEE Trans. Evol. Comp. 8 (2004), 9p.

19467 Minaya Villasana/Gabriela Ochoa: Evolutionary design of cancer
chemotherapies. Internet ca. 2005, 27p.

18594 J. Westman/B. Fabijonas/D. Kern/F. Hanson: Compartmental model
for cancer evolution - chemotherapy and drug resistance.
Internet 2001, 20p.